Ignite Creation Date:
2025-12-25 @ 3:09 AM
Ignite Modification Date:
2025-12-30 @ 9:48 PM
Study NCT ID:
NCT05225805
Status:
COMPLETED
Last Update Posted:
2024-06-17
First Post:
2022-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis
Sponsor:
Nabriva Therapeutics AG
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-13
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-07
First Submit QC Date:
None
Study First Post Date:
2022-02-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-12-28
Results First Submit QC Date:
None
Results First Post Date:
2024-06-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-28
Last Update Post Date:
2024-06-17
Last Update Post Date Type:
ACTUAL